Lung Cancer
MK3475-U01 Master Study: A Phase 1/2, Umbrella Study with Rolling Arms of Investigational Agents, Pembrolizumab, and Chemotherapy, Alone or in Combination, in Participants with Non-small Cell Lung Cancer (NSCLC): MK3475- 01E Sub Study: A Phase 2 Umbrella Study With Rolling Arms of Investigational Agents With or Without Chemotherapy in Combination With Pembrolizumab in Treatment of Participants With Newly Diagnosed Resectable Stages II-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)
- Details
ClinicalTrials.gov ID:
NCT06788912
Diagnosis Type:
NA
USOR Number:
- Address
,
P: